JS
Jagmohan Sharma
About Jagmohan Sharma
Data last updated:
Jagmohan Sharma is a Whole-Time Director at Copmed Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Copmed Pharmaceuticals Private Limited reported revenue of ₹438 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Copmed Pharmaceuticals Private Limited U74899DL1988PTC033151 | Whole-Time Director | 08 Aug 2024 | 1988 | ₹438 Cr (FY 2025) | Active |
Board colleagues of Jagmohan Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhay Kumar Srivastava | 08040683 | Copmed Pharmaceuticals Private Limited | Director |
| Akhlas Ahmed | 08973480 | Copmed Pharmaceuticals Private Limited | Director |
| Anju Kumari Jha | 08141260 | Copmed Pharmaceuticals Private Limited | Director |
| Bhupendra Kaushik | 07016552 | Copmed Pharmaceuticals Private Limited | Director |
| Veer Singh Pal | 01193306 | Copmed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagmohan Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagmohan Sharma
Jagmohan Sharma currently holds 1 directorship: Copmed Pharmaceuticals Private Limited (Whole-Time Director, since 08 Aug 2024, revenue ₹438 Cr (FY 2025)).
Jagmohan Sharma was first appointed on 08 Aug 2024 as Whole-Time Director at Copmed Pharmaceuticals Private Limited.
The current boards of Jagmohan Sharma's companies include Abhay Kumar Srivastava (Copmed Pharmaceuticals Private Limited), Akhlas Ahmed (Copmed Pharmaceuticals Private Limited), Anju Kumari Jha (Copmed Pharmaceuticals Private Limited), Bhupendra Kaushik (Copmed Pharmaceuticals Private Limited), Veer Singh Pal (Copmed Pharmaceuticals Private Limited).